Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Moderna, Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$223.22-3.5%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Moderna sells COVID-19 vaccines mainly to wholesalers, distributors and governments, plus vaccines for respiratory syncytial virus (RSV) and influenza.